Reply to M. Thompson et Al

J Oncol Pract. 2015 May;11(3):263-4. doi: 10.1200/JOP.2015.003897. Epub 2015 Mar 3.

Authors

Blase Polite¹, Jeffery C Ward², John V Cox³, Roscoe F Morton⁴, John Hennessy⁵, Ray Page⁶, Rena M Conti⁷

Affiliations

¹ The University of Chicago, Chicago, IL [email protected].
² Puget Sound Cancer Centers, Seattle, WA.
³ UT Southwestern Medical Center, Dallas, TX.
⁴ Medical Oncology & Hematology Associates, Clive, IA.
⁵ Sarah Cannon Research Institute, Nashville, TN.
⁶ The Center for Cancer and Blood Disorders, Fort Worth, TX.
⁷ The University of Chicago, Chicago, IL.

PMID: 25736384
DOI: 10.1200/JOP.2015.003897

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents / economics*
Humans
Neoplasms / economics*

Substances

Antineoplastic Agents

Grants and funding

UL1 TR000430/TR/NCATS NIH HHS/United States